As global cases of the novel coronavirus (2019-nCoV) surpass 2700 and 4 US states have confirmed 5 travel-associated cases, there is an urgent need now more than ever to
Nancy Messonnier, MD, director of the National Center for Immunization and Respiratory Diseases: "The situation is evolving rapidly."
Testing on human subjects could begin in 3 months.
But “it may become one yet,” warns WHO director-general Tedros Adhanom Ghebreyesus.
Siyang HolyMed in China, the vendor used by Cardinal Health to make the gowns, did so at 2 unapproved sites where the gowns were exposed to air particulate and other contaminants. Employees also ate in the production area.
Panel of WHO health experts will reconvene tomorrow.
Tedros Adhanom Ghebreyesus, MD, the director-general of WHO, said that “never has the threat of antimicrobial resistance been more immediate and the need for solutions more urgent."
The mixed-method, prospective, observational before-after study was performed in a large tertiary academic children’s hospital in the Netherlands and included a preintervention period and an intervention period.
Bug of the Month helps educate readers about existing and emerging pathogens of clinical importance in healthcare facilities today.
Health officials closely monitoring the situation.